Epigenetic regulation during cancer transitions across 11 tumour types
Author:
Terekhanova Nadezhda V., Karpova AllaORCID, Liang Wen-Wei, Strzalkowski Alexander, Chen Siqi, Li YizeORCID, Southard-Smith Austin N.ORCID, Iglesia Michael D.ORCID, Wendl Michael C., Jayasinghe Reyka G.ORCID, Liu Jingxian, Song YizheORCID, Cao Song, Houston Andrew, Liu Xiuting, Wyczalkowski Matthew A.ORCID, Lu Rita Jui-HsienORCID, Caravan WagmaORCID, Shinkle Andrew, Naser Al Deen Nataly, Herndon John M.ORCID, Mudd Jacqueline, Ma Cong, Sarkar Hirak, Sato KazuhitoORCID, Ibrahim Omar M.ORCID, Mo Chia-Kuei, Chasnoff Sara E., Porta-Pardo Eduard, Held Jason M.ORCID, Pachynski Russell, Schwarz Julie K.ORCID, Gillanders William E.ORCID, Kim Albert H.ORCID, Vij Ravi, DiPersio John F.ORCID, Puram Sidharth V.ORCID, Chheda Milan G.ORCID, Fuh Katherine C.ORCID, DeNardo David G., Fields Ryan C.ORCID, Chen FengORCID, Raphael Benjamin J.ORCID, Ding LiORCID
Abstract
AbstractChromatin accessibility is essential in regulating gene expression and cellular identity, and alterations in accessibility have been implicated in driving cancer initiation, progression and metastasis1–4. Although the genetic contributions to oncogenic transitions have been investigated, epigenetic drivers remain less understood. Here we constructed a pan-cancer epigenetic and transcriptomic atlas using single-nucleus chromatin accessibility data (using single-nucleus assay for transposase-accessible chromatin) from 225 samples and matched single-cell or single-nucleus RNA-sequencing expression data from 206 samples. With over 1 million cells from each platform analysed through the enrichment of accessible chromatin regions, transcription factor motifs and regulons, we identified epigenetic drivers associated with cancer transitions. Some epigenetic drivers appeared in multiple cancers (for example, regulatory regions of ABCC1 and VEGFA; GATA6 and FOX-family motifs), whereas others were cancer specific (for example, regulatory regions of FGF19, ASAP2 and EN1, and the PBX3 motif). Among epigenetically altered pathways, TP53, hypoxia and TNF signalling were linked to cancer initiation, whereas oestrogen response, epithelial–mesenchymal transition and apical junction were tied to metastatic transition. Furthermore, we revealed a marked correlation between enhancer accessibility and gene expression and uncovered cooperation between epigenetic and genetic drivers. This atlas provides a foundation for further investigation of epigenetic dynamics in cancer transitions.
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Reference102 articles.
1. Stadhouders, R., Filion, G. J. & Graf, T. Transcription factors and 3D genome conformation in cell-fate decisions. Nature 569, 345–354 (2019). 2. Esteller, M. Epigenetics in cancer. N. Engl. J. Med. 358, 1148–1159 (2008). 3. Butera, A., Melino, G. & Amelio, I. Epigenetic “drivers” of cancer. J. Mol. Biol. 433, 167094 (2021). 4. Alonso-Curbelo, D. et al. A gene–environment-induced epigenetic program initiates tumorigenesis. Nature 590, 642–648 (2021). 5. Buenrostro, J. D., Giresi, P. G., Zaba, L. C., Chang, H. Y. & Greenleaf, W. J. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat. Methods 10, 1213–1218 (2013).
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|